tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Advertisement

Paradigm Biopharmaceuticals (PAR) Similar Shares

Compare
25 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.42
$166.92M
42.37%
1 Buy
0 Hold
0 Sell
Moderate Buy
Imugene
$0.25
$53.62M
-86.02%
0 Buy
0 Hold
0 Sell
Moderate Sell
Alterity Therapeutics
$0.01
$65.30M
0 Buy
0 Hold
0 Sell
Hold
Pharmaust Limited
€0.09
€42.68M
-10.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Recce Pharmaceuticals Ltd.
AU$0.34
AU$96.88M
-25.00%
0 Buy
0 Hold
0 Sell
Hold
Arovella Therapeutics Limited
AU$0.11
AU$124.80M
-34.38%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.42
0.13
42.37%
IUGND
Imugene
0.26
-1.60
-86.02%
PRNAF
Alterity Therapeutics
0.01
0.00
0.00%
DE:ECQ0
Pharmaust Limited
0.09
-0.01
-10.00%
AU:RCE
Recce Pharmaceuticals Ltd.
0.34
-0.12
-26.09%
AU:ALA
Arovella Therapeutics Limited
0.10
-0.06
-37.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis